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ABSTRACT
Background Knowledge of one’s HIV status is the 
gateway to treatment and prevention, but remains low 
among young people. We investigated the early impact 
(2016–2017) of Determined, Resilient, Empowered, 
AIDS- free, Mentored and Safe (DREAMS), a multisectoral 
HIV prevention package, on knowledge of HIV status 
among adolescent girls and young women (AGYW).
Methods In 2017, randomly selected AGYW were 
enrolled into surveys, N=1081 aged 15–22 years in 
Nairobi slum settlements, and N=2174 aged 13–22 
years in rural KwaZulu- Natal. We estimated the causal 
effect of being a DREAMS beneficiary on knowledge of 
HIV status (those who self- reported as HIV- positive or 
tested HIV- negative in the past year), accounting for an 
AGYW’s propensity to be a DREAMS beneficiary.
Results In Nairobi, knowledge of HIV status was higher 
among DREAMS beneficiaries compared with non- 
beneficiaries (92% vs 69%, adjusted OR=8.7; 95% CI 
5.8 to 12.9), with DREAMS predicted to increase the 
outcome by 28%, from 65% if none were a DREAMS 
beneficiary to 93% if all were beneficiaries. The increase 
attributable to DREAMS was larger among younger 
participants: 32% and 23% among those aged 15–17 
and 18–22 years, respectively. In KwaZulu- Natal, 
knowledge of status was higher among DREAMS 
beneficiaries aged 13–17 years (37% vs 26% among 
non- beneficiaries), with a 9% difference due to DREAMS 
(95% CI 4.8% to 14.4%), and no evidence of effect 
among 18–22 years (−2.8%; 95% CI −11.1% to 5.7%).
Conclusion DREAMS substantially increased 
knowledge of HIV status among AGYW in Nairobi, and 
among younger but not older AGYW in KwaZulu- Natal. 
Adolescent girls can be reached early (before age 18) 
with community- based HIV testing programmes in 
diverse high- prevalence settings, with a large impact on 
the proportion who know their HIV status.
INTRODUCTION
Persistently high rates of HIV infection among 
young people, particularly young women, have 
led to large investments in targeted HIV preven-
tion in eastern and southern Africa. This includes 
the ‘Determined, Resilient, Empowered, AIDS- 
free, Mentored and Safe (DREAMS) Partnership’ 
launched in 2015 by the United States’ President’s 
Emergency Plan for AIDS Relief (PEPFAR) and 
private sector partners to promote ‘DREAMS’ 
lives among adolescent girls and young women 
(AGYW). Through a ‘core package’ of 12 evidence- 
based interventions, DREAMS promotes a multi-
sectoral approach to reduce HIV incidence and the 
biological, behavioural, social and economic drivers 
of young women’s heightened risk.1 DREAMS 
is delivered in districts across 15 countries, with 
districts selected on the basis of HIV prevalence and 
incidence estimates.
Enabling young people to know their HIV status 
is an important precursor to halting new infections. 
Knowledge of a positive status is a critical first step 
in linking to life- saving treatment and achieving 
viral suppression, to improve the health of people 
living with HIV/AIDS (PLWHA) and to reduce 
onward transmission. Similarly, confirmation of a 
negative HIV status can link individuals to infor-
mation and prevention services, including highly 
efficacious pre- exposure prophylaxis, to remain 
uninfected.2
Expanded coverage of HIV testing services 
(HTS) has accelerated progress in global testing and 
treatment goals, including the ambition for 90% 
of PLWHA to know they are positive by 2020 (ie, 
the ‘first 90’, in the 90-90-90 ‘fast track’ targets of 
the Joint United Nations Programme on HIV and 
AIDS).3 During 2015–2017, the overall proportion 
of HIV- positive individuals who knew their status 
rose from ~66% to ~75% globally.2 Nevertheless, 
testing remains the largest gap in the HIV treatment 
cascade (between current levels and the target of 
90%), and the gap is largest among young people, 
the rapidly growing demographic group on whom 
epidemic control will depend.4 5 In sub- Saharan 
Africa, less than half of 15–24 years were aware of 
their HIV status in 2017.2
The testing gap among young people suggests they 
are not sufficiently reached by traditional testing 
modes. For example, the most common mode, 
health facility- based testing, is not always avail-
able or acceptable to adolescents. A recent system-
atic review of uptake of HTS among children and 
adolescents (ages 5–19) concluded that ‘approaches 
evaluated to date have not been tailored to needs of 
this age group. Rather, they replicate strategies for 
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adolescents face.’6 The review noted that many young women 
first learn their status when they become pregnant, through 
routine testing in antenatal care. To achieve UNAIDS’ aspiration 
for universal access to HIV testing, approaches must be taken 
to enhance supply, demand and uptake among adolescents and 
young adults.
As part of an ongoing independent impact evaluation of 
DREAMS,7 we sought evidence of an early impact on knowledge 
of HIV status. HIV testing and counseling services are included 
in the DREAMS core package, to be linked (‘layered’) appro-
priately with biomedical, social and educational interventions.1 
Here, we investigate the effect of participation in DREAMS on 
knowledge of HIV status among AGYW in two settings, urban 
Kenya and rural South Africa, after 1 year of DREAMS imple-
mentation. We also sought to elucidate the mechanisms by which 
DREAMS promotes HIV testing in each setting, for example, 
through different DREAMS delivery models and the influence 
of contextual factors on implementation.
METHODS
Study design and settings
In demographic surveillance sites in Nairobi, Kenya and 
KwaZulu- Natal, South Africa, we selected random samples of 
AGYW, stratified by age, for cohort studies for the impact evalu-
ation of DREAMS over 3 years of follow- up.8 9 For this analysis, 
we used 2017 enrolment data from the urban informal settle-
ments of Korogocho and Viwandani in Nairobi, (n=1081 aged 
15–22 years), and from uMkhanyakude district in KwaZulu- 
Natal, (n=2174 aged 13–22). Sample size was calculated to 
ensure statistical power to compare DREAMS beneficiaries 
with non- beneficiaries across multiple outcomes and a range of 
assumptions about DREAMS uptake, within two age groups: 
13–17 and 18–22 years in uMkhanyakude; and 15–17 and 
18–22 years in Nairobi (where 13–14 years were included in a 
separate ‘early adolescent’ cohort aged 10–14 years, building on 
the Global Early Adolescent Study pilot in this setting, and not 
included in this analysis).7 Questionnaires were administered 
in early/mid-2017, approximately 1 year after DREAMS imple-
mentation began. Data were collected electronically on a tablet 
by an interviewer, with the exception of sexual relationship 
questions which were self- filled in uMkhanyakude for privacy. 
Further details of the study settings, including sample size calcu-
lations, sampling strategies and plans for cohort follow- up, are 
described in the study protocol.7
In both settings, DREAMS interventions were first introduced 
in 2016, following efforts to identify and recruit vulnerable 
AGYW (through a door- to- door roster of AGYW supplemented 
with referrals by community- based organisations in Nairobi, 
and through geographical mapping to identify high- incidence 
districts in South Africa, in which all AGYW were considered 
eligible for DREAMS). Early implementation of interventions 
was staggered, with services that had a pre- existing infrastruc-
ture being the first to roll- out, for example, through expanded 
or targeted services to include adolescent girls (aged 15–19 
years) and young women (20–24 years). More detailed descrip-
tions of DREAMS early implementation, including differences 
by context, have been summarised previously.10
Measurement of intervention and outcome
We used receipt of an invitation to DREAMS (self- reported, yes 
or no) as the measure of being a DREAMS beneficiary, regardless 
of whether or how many services were accessed, analogous to an 
‘intention- to- treat’ comparison for a randomised controlled trial 
study design.11 12 An AGYW was defined as knowing her HIV 
status if she self- reported as HIV positive or she reported having 
had an HIV test and received the result within the last 12 months 
(regardless of whether the HIV test was perceived to be affiliated 
with the DREAMS programme or not).
Causal effect of being a dreams beneficiary on knowledge of 
HIV status
The research question is ‘Did DREAMS cause an increase in the 
proportion of AGYW who know their HIV status, in one or both 
of the study settings?’ Phrased with respect to a counterfactual 
outcome, we ask ‘What proportion of AGYW would know their 
HIV status under two hypothetical scenarios: one in which no 
individuals were a DREAMS beneficiary, the other in which all 
individuals were a DREAMS beneficiary.’
Statistical analysis
Sources and measurement of confounding
We constructed setting- specific directed acyclic graphs (DAGs) 
to represent the underlying causal structure of the relation-
ship between being a DREAMS beneficiary, knowledge of HIV 
status, and other individual and household- level characteris-
tics. In the DAGs in figure 1, each node represents a construct 
that is measured by ≥1 characteristic recorded from responses 
to the interview questionnaires. Guided by the work of Green-
land et al,13 each DAG was interrogated to identify the minimal 
set of constructs that needed to be adjusted for to control for 
confounding.
We calculated the observed proportion of AGYW who knew 
their HIV status, by age, site and self- reported DREAMS invi-
tation, and estimated associations between DREAMS invitation 
and knowledge of HIV status and DREAMS invitation, using 
logistic regression to adjust for a priori confounders (age and 
site) and for additional confounding variables informed by the 
DAGs.
Causal effect estimation
To obtain a causal estimate corresponding to the research ques-
tion of interest (articulated above), we used propensity score 
logistic regression adjustment. In our analysis, the propensity 
score is the ‘propensity to be a DREAMS beneficiary’, and is 
defined as the probability of being a DREAMS beneficiary 
given a set of individual and household characteristics.14 15 
The propensity scores were estimated through logistic regres-
sion, with the outcome being a DREAMS beneficiary (invited to 
participate in DREAMS: yes or no), and explanatory variables 
identified as confounding variables from the DAG or as determi-
nants of knowledge of HIV status. In both study sites, we used 
a logistic regression model to estimate the propensity score that 
assumed that the effects of all explanatory variables combined 
multiplicatively, that is, that there was no effect modification on 
the log(odds) scale.
Propensity score logistic regression adjustment was under-
taken by fitting a logistic regression model for the outcome of 
knowledge of HIV status, separately for AGYW who were and 
those who were not DREAMS beneficiaries, with adjustment for 
the propensity score and age group. These two logistic regression 
models were then used to predict the probability of the outcome 
of ‘knowledge of HIV status=yes’ for all AGYW, first under the 
scenario that they were not a DREAMS beneficiary, and second 
under the scenario that they were a DREAMS beneficiary. This 
generated two predicted probabilities for each individual. For 
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all AGYW and also separately for older and younger AGYW. 
These were then used to calculate the marginal percent differ-
ence (the difference in the average predicted probability between 
the scenario in which all AGYW were DREAMS beneficiaries 
and the scenario in which none were DREAMS beneficiaries), 
as well as the corresponding marginal prevalence (risk) ratios 
and ORs.
CIs were generated by using a bootstrap procedure, repeating 
the estimation procedure described above in 1000 samples that 
were drawn with replacement from the complete dataset and 
Figure 1 Directed acyclic graphs to identify causal pathways and confounding factors in Nairobi (A) and uMkhanyakude (B). DREAMS, Determined, 
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calculating 95% CIs from the resulting bootstrap distribution 
using the 2.5% and 97.5% percentiles.
Given the potential for DREAMS to have a different impact 
by age group—since DREAMS targeted adolescent girls 
(15–19 years) and young women (20–24 years) differently—the 
propensity score adjustment approach was applied within age 
groups, as well as overall, with a formal test for effect modifica-
tion by age group.
The assumptions under which our analyses provide a valid 
causal estimate are defined and examined in online supplemental 
file 1. To examine the robustness of the causal effect estimates 
obtained with different assumptions, in addition to propensity 
score logistic regression adjustment we also use three alternative 
approaches, namely: propensity score stratification, propensity 
score weighting and ‘conventional’ multivariable logistic regres-
sion (see online supplemental file 1) for the methods used).
Descriptive analyses and regression analyses for the Nairobi 
setting were conducted in R V.3.4.1 (R Core Team, 2017). All 
analyses for the South African setting were conducted in Stata/
SE 15.1 software (StataCorp, TX).
HIV testing modalities and attitudes
For insight into the delivery of HIV testing in DREAMS 
settings, we summarised respondents’ self- reported experiences 
and modalities of HIV testing over the previous 12 months, 
comparing those invited and not invited into DREAMS, sepa-
rately for two age groups. We also reviewed process evaluation 
data—drawn from structured observations, key informant inter-
views with DREAMS implementers and small group discus-
sions with community and family groups and young people, 
and in- depth interviews with beneficiaries in the first year of 
programme implementation (data described previously)10—
to summarise the approach to delivering HIV testing through 
DREAMS in each context.
RESULTS
In South Africa, 1148 AGYW aged 13–17 and 1036 aged 18–22 
were recruited into closed cohorts (response rate of 85% for 
13–22 year olds, of 2555 eligible). In Nairobi, 547 AGYW aged 
15–17 and 534 aged 18–22 were enrolled (response rate of 61% 
of n=1770 eligible 15–22 years).
Almost half (n=536; 49.6%) of the 1081 participants in 
Nairobi had been invited to participate in DREAMS in the past 
year: 59% of 15–17 years and 40% of 18–22 yeas (table 1A). 
This compares to 29% of all AGYW (n=636/2174) in uMkha-
nyakude, where younger adolescent girls were also more likely 
than young women to be recruited into DREAMS (40% vs 17%, 
13–17 and 18–22 years, respectively) (online supplemental 
tables S1a- b).
Table 1A,B presents the proportion of AGYW who knew their 
HIV status, and differences in this outcome by DREAMS invita-
tion and individual and household characteristics that comprised 
the minimal set of explanatory variables that should be adjusted 
for to control for confounding. This included age, site (slum 
area), education, indicators of socioeconomic status and posi-
tion, and sexual and pregnancy history in Nairobi (table 1A). In 
uMkhanyakude, the confounding set was the same, with loca-
tion distinguishing urban or rural in this setting (table 1B).
Overall, young women’s knowledge of HIV status was higher 
in Nairobi, Kenya, where 81% (n=872) of 1081 participants 
were tested in the past year and/or knew they were HIV- positive, 
compared with 45% (n=977) of 2173 respondents surveyed in 
uMkhanyakude, South Africa. Knowledge of status increased 
with age in both settings: rising from 73% to 91% between 
the ages of 15 and 22 years in Nairobi, and from 14% to 65% 
between ages 13 and 22 years in uMkhanyakude. In Nairobi, the 
strongest association between an individual or household char-
acteristic and knowledge of HIV status was with invitation to 
DREAMS (age- site- adjusted OR=7.3, 95% CI 4.99 to 10.75), 
followed by sexual/reproductive history, age, perception of 
household poverty, area of residence and education (table 1A). In 
uMkhanyakude, the association between invitation to DREAMS 
and knowledge of HIV status was much weaker than in Nairobi 
(age- location- adjusted OR=1.27, 95% CI 1.03 to 1.57), with 
strong evidence of associations with sexual/reproductive history 
and age, and weak evidence of an association with food security 
(table 1B).
In age- stratified analysis, the association between the outcome 
and history of pregnancy was greater among the younger than 
the older girls, with 81% of 13–17 years knowing their status if 
they had been pregnant compared with only 27% among those 
who had never been pregnant (OR=7.48, 95% CI 3.84 to 14.57; 
online supplemental table S1a). Urban or rural location was 
associated with knowledge of status among the younger girls in 
KwaZulu- Natal, with 13–17 years in urban/periurban areas less 
likely than those in rural areas to know their status (OR=0.78, 
95% CI 0.58 to 1.03; online supplemental table S1a), but there 
was no evidence of such association among the 18–22 years 
(online supplemental table S1b).
Causal effect of DREAMS invitation on knowledge of HIV 
status
In Nairobi, knowledge of HIV status was higher among AGYW 
who were DREAMS beneficiaries compared with AGYW 
who were not DREAMS beneficiaries (92% vs 69%; adjusted 
OR=8.7, 95% CI 5.8 to 12.9; table 2). In propensity score 
regression adjusted analysis, DREAMS was estimated to increase 
knowledge of HIV status by 28%, from 65% if no AGYW were a 
DREAMS beneficiary to 93% if all were a DREAMS beneficiary 
(95% CI 22.8 to 32.6; table 3, figure 2). This represents the per 
cent difference attributable to DREAMS (the ‘marginal causal 
percent difference’), after controlling for confounding variables 
using regression adjustment for the propensity score. The effect 
was larger among younger than older participants: 93% vs 61% 
among beneficiaries vs non- beneficiaries aged 15–17 years (32% 
difference attributable to DREAMS; 95% CI 24.9 to 39.1) and 
94% vs 71% (23% difference due to DREAMS, 95% CI 15.0 
to 29.7) among those aged 18–22 years. Alternative measures 
of effect, including marginal prevalence and ORs, also provided 
strong evidence that DREAMS had an effect on knowledge of 
HIV status (table 3).
In uMkhanyakude, there was a smaller increase in knowledge 
of HIV status by DREAMS invitation, relative to Nairobi, with 
weak evidence of an overall difference attributable to DREAMS 
of 3.6% (95% CI −1.9% to 8.4%; table 3). There was evidence 
that the effect of DREAMS differed by age group, with evidence 
of effect only among 13–17 years. Specifically, the effect of 
DREAMS was estimated to increase knowledge of HIV status 
by 9% (95% CI 4.8% to 14.4%), from 26.5% if no- one was a 
DREAMS beneficiary to 35.4% if all were a DREAMS benefi-
ciary among 13–17 years, compared with no evidence of effect 
among 18–22 years (−2.8%, 95% CI −11.1% to 5.7%; table 3, 
figure 2). The findings were similar using other measures of 
effect, with differences in odds and prevalence ratios observed 
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Table 1 Characteristics of DREAMS beneficiaries and non- beneficiaries according to factors identified in the DAG, in Nairobi (A) and 
uMkhanyakude (B)
(A) Nairobi Total DREAMS beneficiaries Non- beneficiaries
N % (col) N % (col) N % (col)
Age group
  15–17 years 547 50.6 322 60.07 225 41.28
  18–22 years 534 49.4 214 39.93 320 58.72
Age
  15 years 156 14.43 94 17.54 62 11.38
  16 years 203 18.78 126 23.51 77 14.13
  17 years 188 17.39 102 19.03 86 15.78
  18 years 138 12.77 76 14.18 62 11.38
  19 years 95 8.79 37 6.9 58 10.64
  20 years 102 9.44 41 7.65 61 11.19
  21 years 94 8.7 31 5.78 63 11.56
  22 years 105 9.71 29 5.41 76 13.94
Location
  Korogocho 617 57.08 314 58.58 303 55.6
  Viwandani 464 42.92 222 41.42 242 44.4
Current school status
  Currently in school 626 57.91 371 69.22 255 46.79
  Not in school 455 42.09 165 30.78 290 53.21
Highest education
  Primary incomplete 125 11.56 55 10.26 70 12.84
  Primary grade 8 217 20.07 92 17.16 125 22.94
  Secondary form 1 154 14.25 96 17.91 58 10.64
  Secondary form 2 187 17.3 110 20.52 77 14.13
  Secondary form 3 150 13.88 86 16.04 64 11.74
  Secondary form 4 198 18.32 74 13.81 124 22.75
  Tertiary 50 4.63 23 4.29 27 4.95
Household assets
  Low asset score 361 33.4 190 35.45 171 31.38
  Middle asset score 360 33.3 172 32.09 188 34.5
  High asset score 360 33.3 174 32.46 186 34.13
Poverty perception
  Very poor 139 12.86 77 14.37 62 11.38
  Moderately poor 858 79.37 424 79.1 434 79.63
  Not poor 84 7.77 35 6.53 49 8.99
Credit access
  No access to credit 550 50.88 265 49.44 285 52.29
  Access to credit 483 44.68 250 46.64 233 42.75
  Don't know 48 4.44 21 3.92 27 4.95
Ever had sex
  Ever had sex 437 40.43 157 29.29 280 51.38
  Never had sex/undisclosed 644 59.57 377 70.34 267 48.99
Ever pregnant
  Ever pregnant 299 27.66 101 18.84 198 36.33
  Never had sex 644 59.57 379 70.71 265 48.62
  Ever had sex, never pregnant 138 12.77 56 10.45 82 15.05
(B) uMkhanyakude Total DREAMS beneficiaries Non- beneficiaries
N % (col) N % (col) N % (col)
Age category
  13–17 years 1143 52.6 460 72.33 683 44.44
  18–22 years 1030 47.4 176 27.67 854 55.56
Age
  13 years 236 10.86 88 13.84 148 9.63
  14 years 222 10.22 76 11.95 146 9.5
  15 years 232 10.68 102 16.04 130 8.46
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In both settings, effect estimates generated through alterna-
tive approaches to propensity score regression adjustment (ie, 
stratification and weighting) were similar (online supplemental 
table S2).
HIV testing experiences and modalities
In Nairobi, levels of confidence about getting an HIV test and 
knowledge of where to get tested were very high (90% and 99%, 
respectively) across age groups and among both beneficiaries and 
non- beneficiaries of DREAMS (online supplemental table S3a). 
Testing in the past 12 months was more frequently reported 
by DREAMS beneficiaries than non- beneficiaries, among both 
age groups (89% vs 47% among the younger and 90% vs 73% 
among the older cohort). When asked where they tested most 
recently, mobile health facilities were more commonly reported 
among adolescent girls (<18 years) than young women (21% 
vs 15%), with no differences by DREAMS invitation. Overall, 
few participants reported home testing (<9%) or self- testing 
(<1%). DREAMS beneficiaries were more likely than non- 
beneficiaries to say their last test had been ‘offered’ to them (eg, 
52 vs 29% among 15–17 years) or ‘required’ (eg, 29% vs 15% 
of non- beneficiaries among adolescent girls). Older participants 
and non- DREAMS beneficiaries more frequently said they ‘had 
asked for the test’.
Most AGYW in Nairobi (65%) reported that their motivation 
for testing was to protect or take care of themselves (with higher 
reporting of this among DREAMS beneficiaries, in both age 
groups). Testing to protect an unborn/future child was reported 
mostly by older participants, especially non- DREAMS beneficia-
ries (13%) vs 5% of beneficiairies. Among those who reported 
not testing for HIV in the past year (n=125), the most common 
reason was ‘I don’t think I have HIV’ (68%), an answer more 
commonly reported by young adolescents (71% vs 63% of older 
participants), especially adolescents who were not invited into 
DREAMS (75% vs 46% of DREAMS beneficiaries). Few AGYW 
(n=11) did not want to know their HIV status.
As in Nairobi, AGYW in uMkhanyakude expressed high levels 
of confidence about getting an HIV test if they wanted one (93% 
overall), including visiting a health facility to get tested (online 
supplemental table S4). Almost all (>95%) felt it is important 
for people to know their HIV status. Relatively few had tested 
in a health facility in the past 12 months: 18% of 13–17 years 
and 41% of 18–22 years. Home- based testing in the past year 
was higher among the young beneficiaries (27% vs 19% of 
(B) uMkhanyakude Total DREAMS beneficiaries Non- beneficiaries
N % (col) N % (col) N % (col)
  17 years 213 9.8 91 14.31 122 7.94
  18 years 243 11.18 63 9.91 180 11.71
  19 years 228 10.49 47 7.39 181 11.78
  20 years 242 11.14 36 5.66 206 13.4
  21 years 174 8.01 21 3.3 153 9.95
  22 years 143 6.58 9 1.42 134 8.72
Location
  Rural 1383 64.21 457 72.66 926 60.72
  Periurban/urban 771 35.79 172 27.34 599 39.28
Socioeconomic status
  Low 720 34.88 248 40.52 472 32.51
  Middle 746 36.14 209 34.15 537 36.98
  High 598 28.97 155 25.33 443 30.51
Currently in school
  No 538 24.76 66 10.38 472 30.71
  Yes 1635 75.24 570 89.62 1065 69.29
Level of education
  Primary 206 9.49 75 11.79 131 8.53
  Secondary 1628 74.99 520 81.76 1108 72.18
  Completed matric 337 15.52 41 6.45 296 19.28
Ever migrated
  No 1771 81.5 564 88.68 1207 78.53
  Yes 402 18.5 72 11.32 330 21.47
Food insecurity
  No 1495 68.8 495 77.83 1000 65.06
  Yes 678 31.2 141 22.17 537 34.94
Ever been/currently pregnant
  No 1570 73.95 539 85.83 1031 68.96
  Yes 553 26.05 89 14.17 464 31.04
Sexually active
  Ever pregnant 553 26.18 89 14.26 464 31.18
  Never pregnantandsexually active 248 11.74 58 9.29 190 12.77
  Never pregnantandnot sexually active 39 1.85 10 1.6 29 1.95
  Never had sex 1272 60.23 467 74.84 805 54.1
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non- beneficiaries), while there were no differences in recent 
use of mobile or partner testing by DREAMS invitation. As in 
Nairobi, few AGYW used HIV self- testing in the past year (<2% 
overall).
HTS delivered through DREAMS
Process evaluation data showed that the ways in which HTS were 
delivered through DREAMS varied considerably in each setting 
(see box 1 below). In Nairobi, testing services were ‘centralised’ 
through one implementing agency which offered testing to 
all AGYW beneficiaries at the time of DREAMS enrolment, 
regardless of age, circumstance or perceived risk. In contrast, 
in uMkhanyakude, HTS were delivered by multiple DREAMS 
implementers and AGYW were linked to testing through commu-
nity mobilisation events or during SRH or ante- natal care service 
provision. In both settings, testing was available in community- 
based settings (eg, ‘safe spaces’ and tents set up for DREAMS in 
Nairobi and uMkhanyakude, respectively, and some home- based 
testing) as well as referrals to primary health facilities.
DISCUSSION
Key findings
In large, representative samples of young women in two diverse 
settings, we assessed the early impact of the DREAMS Partner-
ship on an important precursor to reducing HIV incidence: 
knowledge of HIV status. In both settings, we found that expo-
sure to DREAMS (a multisectoral HIV prevention intervention 
for AGYW) led to an increase in knowledge of HIV status among 
the younger cohort (those aged <18 years at enrolment). This 
increase was more substantial in Kenya (32%) compared with 
South Africa (9%). DREAMS also increased knowledge of HIV 
status among the older cohort of young women (18–22 years) in 
Nairobi (by 23%) but not in uMkhanyakude. We have shown in 
previous research that DREAMS was more effective at recruiting 
younger adolescents than the older target group in its first year 
of implementation.16 Here, we see how that may translate 
into greater evidence of impact among the younger adolescent 
beneficiaries.
The weaker effect of DREAMS on older participants’ knowl-
edge of status could be due to the programme’s poorer reach 
of this age group in general, as well as the higher availability, 
accessibility and motivation to use existing HTS among the 
older group, for example, through existing antenatal care, 
prevention of mother- to- child transmission programmes, post-
natal care and other services already used by young women 
(especially where pregnancy rates increase rapidly from age 
18, as in South Africa).17 While DREAMS was still effective 
at reaching more women >18 years with testing in Nairobi, 
that is, more than expected without DREAMS, it was not so in 
uMkhanyakude.
Table 2 Association of DREAMS with knowledge of HIV status using conventional logistic regression: unadjusted risk (%) difference and 
unadjusted and adjusted ORs, overall and stratified by age






















  Overall‡ 545(50.4) 536(49.6) 69.36 92.16 22.80 5.20 (3.61 to 7.48) 7.32 (4.99 to 10.75) 8.69 (5.84 to 
12.93)
<0.001
  15–17 years§ 225(41.1) 322(58.9) 54.67 90.37 35.70 7.78 (4.94 to 12.26) 7.90 (4.99 to 12.51) 9.45 (5.82 to 
15.36)
<0.001




  Overall¶ 1537(70.4) 636(29.3) 46.3 41.8 −4.5 0.84 (0.69 to 1.01) 1.27 (1.03 to 1.57) 1.40 (1.12 to 
1.75)
0.003
  13–17 years** 683(59.8) 460(40.2) 26.2 36.7 10.5 1.64 (1.27 to 2.11) 1.50 (1.15 to 1.97) 1.61 (1.22 to 
2.15)
0.001
  18–22 years** 854(82.9) 176(17.1) 62.3 55.1 −7.2 0.74 (0.54 to 1.03) 0.84 (0.60 to 1.18) 0.94 (0.65 to 
1.37)
0.749
*Adjusted for minimal set of confounders identified in the DAGs (see final column of online supplemental tables S1a,b and S2a,b) for details).
†Statistical test for interaction provided evidence for interaction by age group in uMkhanyakude (p<0.001) and not in Nairobi (p=0.886).
‡See online supplemental table S1a for more details.
§See online supplemental table S2a for more details.
¶See online supplemental table S1b for more details.
**See online supplemental table S2b for more details.
DAGs, directed acyclic graphs; DREAMS, Determined, Resilient, Empowered, AIDS- free, Mentored and Safe.
Table 3 Estimated causal effect of DREAMS on knowledge of HIV status, from regression analysis with adjustment for the ‘propensity to be a 






know status if 
none benefit 
from DREAMS 95% CI
Estimated % 
Know status if 
all benefit from 
DREAMS 95% CI
Marginal 
causal per cent 
difference (%)
(PS adjusted) 95% CI
Prevalence 
ratio
(PS adjusted) 95% CI
OR
(PS adjusted) 95% CI PAF* 95% CI
Nairobi       
  Overall 80.67 65.1 (60.9 to 69.5) 92.9 (90.6 to 95.0) 27.77 (22.8 to 32.6) 1.43 (1.33 to 1.53) 6.98 (4.84 to 10.47) 19.3
  15–17 years 75.69 61.1 (53.9 to 67.7) 92.8 (89.9 to 95.2) 31.76 (24.9 to 39.1) 1.52 (1.37 to 1.72) 8.26 (5.46 to 13.83) 19.28
  18–22 years 85.77 70.9 (64.4 to 78.2) 93.5 (89.6 to 97.0) 22.61 (15.0 to 29.7) 1.32 (1.19 to 1.47) 5.93 (3.16 to 13.34) 17.34
uMkhanyakude       
  Overall 44.96 42.30 (39.79 to 44.74) 45.87 (40.75 to 49.97) 3.57 (−1.92 to 8.35) 1.08 (0.96 to 1.20) 1.16 (0.92 to 1.40) 5.90 (2.37 to 9.36)
  13–17 years 30.45 26.49 (23.18 to 30.08) 35.43 (32.13 to 38.95) 8.95 (4.81 to 14.41) 1.38 (1.17 to 1.62) 1.52 (1.26 to 2.00) 13.01 (7.41 to 21.74)
  18–22 years 61.07 61.15 (57.82 to 64.53) 58.31 (50.24 to 63.90) −2.84 (−11.11 to 5.67) 0.95 (0.82 to 1.07) 0.89 (61.12 to 1.19) −0.14 (−2.98 to 2.81)
*PAF estimate as ((% know status in the total study population) – (predicted % who know status if no DREAMs))/% know status in the total study population.
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The stronger effect of DREAMS in Nairobi relative to uMkh-
anyakude is likely to be influenced by the delivery of HIV testing 
in each context. In Nairobi, HIV testing was offered systemati-
cally by one implementing agency to all DREAMS recruits, at the 
time of enrolment, regardless of age, circumstance or perceived 
risk and administered in DREAMS- specific sites (community- 
based clinics and ‘safe space’ venues dedicated to DREAMS 
beneficiaries). In contrast, HTS through DREAMS were less 
coordinated and less centralised in uMkhanyakude, and only 
42% of all DREAMS beneficiaries knew their HIV status. The 
increased knowledge of status observed among younger adoles-
cents in uMkhanyakude may have been due to community- 
mobilisation events (not provided before DREAMS), where 
they were informed about testing and offered on- site testing in 
tents, as well as referrals via other DREAMS interventions and 
increased home- based testing. (Testing in health facilities over 
the past year did not differ among DREAMS beneficiaries and 
non- beneficiaries in this setting.) Another contextual differ-
ence may be the degree to which DREAMS clients felt able to 
decline HIV testing. DREAMS’ approach to HTS was pro- active 
in Nairobi and beneficiaries most often described their latest 
HIV test as ‘offered’ (45%) or ‘required’ (28%). Among bene-
ficiaries, testing may have been viewed as an entry point to the 
DREAMS programme and its benefits, and an incentive to HIV 
testing may have been perceived by potential beneficiaries or 
their guardians. In uMkhanyakude, where HIV testing through 
DREAMS was less systematic or proactive, self- initiated testing 
was more common. Those who were not recently sexually active 
or perceived themselves to be at low- risk, may not have sought 
testing even if availability increased.
These findings are consistent with recommendations to boost 
community- based HIV testing opportunities, as a way to increase 
uptake among young people.6 Offering testing through ‘safe 
spaces’ for AGYW, mobile units, events, home- based testing, 
mHealth and peer outreach, provides alternatives to facility- 
based testing that is not always acceptable, available or afford-
able to adolescents.18 19 Key barriers expressed by adolescents 
include ‘unfriendly’ services and concerns about confidentiality, 
and the perceived need to be sick to use primary healthcare facil-
ities.20 ‘Enhanced peer outreach’ by HIV- positive peer mobilisers 
has been shown to improve HIV testing yield (new diagnoses) 
among key populations, including female sex workers, in DRC 
and Haiti,21 and may be an effective way to encourage adoles-
cents choosing to test for the first time. Integrating HIV coun-
selling and testing with family planning services—demonstrated 
What is already known on this subject
 ► Knowledge of one’s HIV status is a critical first step in linking 
into treatment and prevention services, and stemming 
onward transmission.
 ► Testing rates remain comparatively low among adolescents 
and young people, a rapidly growing demographic group in 
Africa upon whom HIV epidemic control depends.
 ► Complex interventions are increasingly recommended for HIV 
prevention yet few are delivered at scale or evaluated in real- 
world settings.
Figure 2 Proportion of AGYW who know their HIV status if none 
versus all benefit from DREAMS, by age and setting. AGYW, adolescent 
girls and young women; DREAMS, Determined, Resilient, Empowered, 
AIDS- free, Mentored and Safe.
Box 1 Models of delivering HIV testing through dreams 
in each setting
Nairobi, Kenya
In the two informal settlement areas of Nairobi, HIV testing 
services (HTS) were coordinated and delivered by one 
implementing partner (IP) per area. Both IPs were experienced 
in HTS provision prior to Determined, Resilient, Empowered, 
AIDS- free, Mentored and Safe (DREAMS). All adolescent girls 
and young women (AGYW) who were recruited into DREAMS 
were eligible for HIV testing and offered testing at the time of 
an enrolment interview for DREAMS. AGYW received their result 
at the time of the test and were referred to interventions based 
on their status and other factors (eg, sexual/pregnancy history, 
experience of violence). Testing was usually administered in a 
community site clinic established for DREAMS (in a compound 
with a coordination office), or in DREAMS ‘safe spaces’, such 
as community halls, churches and other local venues used 
for delivery of DREAMS interventions. Caregiver consent was 
required for those aged <15 years, and girls aged 15+ years 
could provide their own consent. Family testing services were 
also available within the homes of DREAMS beneficiaries, to 
those seeking this service, and walk- in clients (AGYW and males 
not enrolled in DREAMS) could seek HTS within the site clinics.
uMkhanyakude, South Africa
In uMkhanyakude, KwaZulu- Natal, HTS were delivered by 
multiple DREAMS IPs in the same areas (20 municipal wards). 
Prior to DREAMS, the IPs were experienced in provision of HTS 
in other geographical areas, and DREAMS funding enabled 
expansion into uMkhanyakude. DREAMS IPs used a variety 
of approaches to offer HTS. For example, some identified 
AGYW through community mobilisation events and provided 
information and a referral to testing services. HIV testing was 
administered to consenting AGYW within communities, for 
example, in tents, as well as public health care facilities where 
HIV testing was integrated with sexual reproductive health 
services and antenatal care. Some IPs provided door- to- door 
testing, primarily to target male sexual partners of AGYW, but 
offered HTS to AGYW in the households they visited. IPs that 
were not contracted to provide HTS issued referrals to AGYW 
participating in other DREAMS programmes such as school- 
based or community- based interventions, parenting programmes 
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in the Integra trial in Kenya and Swaziland—can also boost 
early testing, and simultaneously prevent HIV and unplanned 
pregnancy.22 23 Providing a mix of testing modalities, including 
HIV self- testing (directly and peer- assisted self- testing)24 25 may 
ensure the choice and confidentiality that adolescents, a hetero-
geneous group, need in order to be able to access HTS and know 
their HIV status.
Strengths and limitations
A strength of the study is that the findings are unlikely to be 
explained by confounding or selection bias. The representa-
tive samples include AGYW who were and were not invited to 
participate in DREAMS, and we were able to take into account 
any systematic differences between those groups. We applied 
a causal inference framework to control for confounding by 
individual and household characteristics that were anticipated 
to be determinants of both DREAMS invitation and knowledge 
of HIV status, and we made comparisons and causal effect esti-
mates that are analogous to an ‘intention to treat’ analysis for 
a trial design.11 12 We estimated several alternative causal effect 
measures and found a consistent pattern across all. We also 
compared the main analytical approach (propensity score regres-
sion adjustment) with other methods to control for confounding 
using propensity scores, such as propensity score stratification 
and weighting, as well as with conventional multivariable logistic 
regression. Findings were similar across these approaches, giving 
confidence that the magnitude and direction of the estimated 
overall causal effect is robust to different analytical approaches, 
although all relied on the same interview data (to measure 
outcomes, exposures and confounders) and were thus equally 
subject to any bias in those data.
Because DREAMS was not a randomised intervention, it was 
essential to identify key determinants of being a DREAMS bene-
ficiary and we relied on self- reported invitation into DREAMS 
to distinguish DREAMS beneficiaries and non- beneficiaries. 
This may have led to misclassification, and possibly have under-
estimated the percentage of AGYW who were DREAMS bene-
ficiaries, if AGYW did not recall an ‘invitation’ to DREAMS, 
or they were invited but did not receive any interventions. Our 
approach also estimated an overall effect of DREAMS regard-
less of which DREAMS interventions AGYW actually received. 
Nevertheless, in previous analyses, we found a strong correlation 
between invitation to DREAMS and uptake of ‘core package’ 
interventions, with almost all who were invited to DREAMS 
receiving multiple interventions, and large differences in the 
number of ‘core package’ interventions received by those invited 
to DREAMS compared with those who were not invited.16
CONCLUSION
South Africa and Kenya are experiencing the first and fourth 
largest HIV epidemics, respectively.26 Among the growing number 
of young people in these and other African countries, new infec-
tions will continue as long as knowledge of HIV status—among 
HIV- positive individuals (‘the First 90%’) and among all indi-
viduals regardless of HIV status—remains low. This evaluation 
of DREAMS’ initial impact demonstrates that adolescent girls 
can be reached early (before age 18) with HTS and learn their 
HIV status before first pregnancy and antenatal care—often 
when many adolescents test for the first time.6 Promoting the 
value of knowing your HIV status and making voluntary testing 
services available outside of clinical services—where adolescents 
can be encouraged and not judged for testing—can prepare 
young people to test more regularly, to protect their own health 
and plan for their future. In follow- up rounds, we will evaluate 
the sustained effect of DREAMS on HIV testing, and whether it 
successfully links young women from testing into treatment and 
prevention, for an impact on HIV incidence.
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What this study adds
 ► We applied a causal inference framework to estimate the 
causal effect of being a beneficiary of the Determined, 
Resilient, Empowered, AIDS- free, Mentored and Safe 
(DREAMS) partnership on knowledge of HIV status.
 ► DREAMS quickly and substantially increased knowledge of 
status among adolescent girls (<18 years) in both urban 
Kenya and rural South Africa.
 ► The impact of DREAMS was stronger in Kenyan settings, 
where HIV testing was coordinated by one implementing 
partner per area, and offered more pro- actively and 
systematically than in South Africa.
 ► A large- scale complex intervention implemented in real- 
world conditions can have direct and early effects on HIV 
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